Skip to main content

Peer Review reports

From: Evaluating cost per remission and cost of serious adverse events of advanced therapies for ulcerative colitis

Original Submission
5 Jan 2022 Submitted Original manuscript
11 Apr 2022 Reviewed Reviewer Report - Amanda R. Tatro
26 Apr 2022 Reviewed Reviewer Report
15 May 2022 Reviewed Reviewer Report
3 Aug 2022 Author responded Author comments - Vipul Jairath
Resubmission - Version 2
3 Aug 2022 Submitted Manuscript version 2
5 Aug 2022 Reviewed Reviewer Report
4 Nov 2022 Author responded Author comments - Vipul Jairath
Resubmission - Version 3
4 Nov 2022 Submitted Manuscript version 3
15 Nov 2022 Author responded Author comments - Vipul Jairath
Resubmission - Version 4
15 Nov 2022 Submitted Manuscript version 4
Publishing
21 Nov 2022 Editorially accepted
6 Dec 2022 Article published 10.1186/s12876-022-02590-6

You can find further information about peer review here.

Back to article page